Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
(S)-N-(3-Indol-1-Yl-2-Methyl-Propyl)-4-Sulfamoyl-Benzamide
- Development stage
- Unknown
- Lead developer
- Harvard University
- Modality
- Small Molecules
01
Overview
(S)-N-(3-Indol-1-Yl–2-Methyl–Propyl)–4-Sulfamoyl–Benzamide is an experimental small molecule inhibitor of human carbonic anhydrase II. It was designed using a combinatorial computational method to bind with high affinity to the enzyme, and structural studies confirm its binding mode. The compound is not approved for clinical use and has no known marketed indications. Its primary mechanism is inhibition of carbonic anhydrase II, which plays a role in pH regulation and fluid balance in various tissues[7][8][1].
- Other names
- N-(3-Indol-1-Yl-2-Methyl-Propyl)-4-Sulfamoyl-BenzamideBenzamide, 4-(aminosulfonyl)-N-[(2S)-3-(1H-indol-1-yl)-2-methylpropyl]-N-[ (2S) -3-(1H-Indol - 1 - yl ) - 2-methylpropyl ] - 4-sulfamoylbenzamidN-[ (2S) -3-(1H-Indol - 1 - yl ) - 2-méthylpropyl ] - 4-sulfamoylbenzamide
02
Targets
CA2 (Carbonic Anhydrase 2)
Beyond the preview
Go deeper on (S)-N-(3-Indol-1-Yl-2-Methyl-Propyl)-4-Sulfamoyl-Benzamide.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on (S)-N-(3-Indol-1-Yl-2-Methyl-Propyl)-4-Sulfamoyl-Benzamide.